Physician profile

Jonathan J Goodman

Surgery · Sun City, AZ

NPI 1902845134

$27,768.14

in general payments reported to CMS, 2019-2025

7 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Education$4,036.19
Food and Beverage$1,311.09
Travel and Lodging$442.05
Gift$212.28

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Intuitive Surgical, INC. $27,655.77 2019-2024 Da Vinci Surgical System
Pacira Pharmaceuticals Incorporated $24.31 2019
Abbott Laboratories $21.76 2019
Innovation Technologies INC $20.95 2024 Irrisept
Allergan, INC. $18.07 2019
Shire North American Group INC $16.06 2019
Lemaitre Vascular, INC. $11.22 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Jonathan J Goodman

$27,768.14

in general payments reported 2019-2025

Years
2019-2024
Top company
Intuitive Surgical, INC.

https://glasscript.com/doctor/844299/jonathan-j-goodman

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.